2012 annual financial data

Madrigal Pharmaceuticals, Inc. 2012 Net margin

Madrigal Pharmaceuticals, Inc. 2012 net margin with verified reported values.

Direct answer

Net margin was -42,714.29%.

Operating income was -61,088,000 USD and net income was -62,790,000 USD.
Operating cash flow was -54,135,000 USD.

Get free Madrigal Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
147,000 USD
Operating income
-61,088,000 USD
Net income
-62,790,000 USD
Operating cash flow
-54,135,000 USD